Pfizer account map & org chart

Nine executives report to Chairman and CEO Albert Bourla³. Chris Boshoff runs Research & Development. Aamir Malik runs the U.S. commercial division and Alexandre de Germay runs the international one. Mike McDermott runs Pfizer Global Supply. Oncology R&D used to be its own division; since January 2025 it sits inside R&D under Chief Oncology Officer Jeff Legos. Chief Medical Officer Patrizia Cavazzoni and Chief Internal Medicine Officer James List also sit inside R&D.

• We found 627 Pfizer teams hiring in the past four quarters, and 5,951 leaders at Director level or above. All of it from public sources.
• Vaccines hires the most: 118 open roles in the past four quarters, 3.1 times its previous four. Clinical Data Sciences is growing fastest, from 3 roles to 18. Across the company, postings grew 1.5 times.
• Most of the hiring is in the United States (1,641 location listings), then India (241) and China (203). New York is the busiest city, with 340.
• Pfizer reports its business in two segments: the Global Biopharmaceuticals Business (Biopharma) and Pfizer CentreOne (PC1)¹.

The 30 most active units by open roles in the trailing four quarters, of 627 units with any hiring activity in the window (drawn from 3,568 verbatim-extracted unit-name candidates). Rows are centers of activity, not an org chart — several (therapeutic areas especially) sit inside larger divisions rather than beside them. = corroborated by 2+ independent sources.

Reading the momentum column

Momentum is the unit's own posting count, last four quarters vs the four before: ▲ 2.0× = twice as many postings. The arrow marks units moving well beyond (or against) the company-wide trend, so growth that merely tracks a general surge shows its multiple without an arrow. Too little history shows "—" rather than a noisy number.

How to use this page. A unit gaining hiring share is standing up capacity — the best moment to engage is while teams and tooling are still being chosen. A unit losing share may be post-reorg, outsourcing, or completing a build-out; treat the flag as a prompt to ask, not a conclusion.

Posting locations for the trailing four quarters of hiring, aggregated across all mapped units. Counts are location listings — a posting advertised in several locations counts once per location, so totals exceed distinct postings. Use this to route territory and plan on-site coverage.

Named Director+ leadership for the busiest centers of work. Every row is flagged for currency: verified = web-checked as current during this snapshot's verification pass; current = active primary position, recently confirmed; verify = sourced but not recently re-confirmed — check before outreach. In this public edition, a lock marks a leader named in the full map.

Pfizer's stated leadership structure, drawn as reported: the nine-member executive leadership team reports to the CEO³, and every numbered superscript links to its source — Pfizer's own leadership page, SEC filings, and press releases. A blue count on a card marks a division whose internal structure is mapped in the following sections: official sub-organizations as boxes, observed teams as ◦ chips. Badges mark Pfizer's financial-reporting segments — a reporting grouping, not a management chain.

Reading order for the next two sections: Research & Development first — the largest mapped division — then the commercial divisions and supply. Chief-officer reporting lines inside R&D (Internal Medicine, Oncology, Medical) are drawn where those officers sit.

Boxes are official, cited organizations — each superscript links to its source. Muted chips marked ◦ are teams observed in Pfizer's hiring activity and scientific literature (the mined corpus behind the rest of this map), attached beneath the official unit they sit in; a gray "4 roles·4q" means 4 open roles observed for that team in the trailing four quarters. Where Medical organizations appear inside R&D, that is Pfizer's stated structure: the Chief Medical Officer reports to the CSO & President, Research & Development (announced February 2025).

The two commercial divisions and Pfizer Global Supply, mapped the same way — official cited boxes, observed ◦ chips — with Pfizer's reporting segments below.

How is Pfizer organized in 2026?

Nine executives report to Chairman and CEO Albert Bourla³. Chris Boshoff runs Research & Development, Aamir Malik runs U.S. Commercial, Alexandre de Germay runs International Commercial, and Mike McDermott runs Pfizer Global Supply. The corporate functions are finance (Cécile Guégan, interim), legal (Doug Lankler), people experience (Payal Sahni Becher), IT (Dennis Hancock), and strategy (Lindsay Havern). Pfizer reports its business in two segments: Biopharma and Pfizer CentreOne.

Who leads Pfizer's research and development?

Chris Boshoff, Chief Scientific Officer and President of Research & Development. Oncology R&D used to be its own division; since January 2025 it reports into R&D under Chief Oncology Officer Jeff Legos. Chief Medical Officer Patrizia Cavazzoni and Chief Internal Medicine Officer James List also sit inside R&D.

Which Pfizer units are hiring the fastest in 2026?

Compared with the four quarters before, Clinical Data Sciences grew 6 times (3 roles to 18), Clinical Pharmacology 3.3 times (3 to 10), Vaccines 3.1 times (38 to 118), Research and Development 2.8 times (4 to 11), Internal Medicine 2.6 times (16 to 42), and Hematology 2.1 times (14 to 30). Postings across the company grew 1.5 times, so all six are growing faster than Pfizer as a whole. Vaccines posts the most roles overall.

Where is Pfizer hiring?

Mostly in the United States, which accounts for 1,641 location listings. The busiest cities are New York (340), Cambridge (84), Tampa (75), and Bothell (67). Outside the U.S., India has the most (241 listings, mainly Chennai and Mumbai), then China (203, mainly Shanghai and Beijing).

What is an account map?

A view of a large company one level below the org chart: the named teams and departments where budgets get spent and vendors get chosen. We rank them by hiring activity and show who leads them, using only what the company makes public. That means job postings, scientific papers, leadership pages, and SEC filings. This page is the redacted version; the full PDF names every leader we identified.